Alnylam initiates ILLUMINATE-B phase 3 pediatric study of Lumasiran to treat primary hyperoxaluria type 1 Read more
Allele Biotechnology and SCM Lifescience Sign a Joint Research and Development Agreement to Develop iPSC-based Diabetes Treatment Read more
Sutter Health, UPMC, and DNAnexus Initiate Collaboration to Improve Personalized Treatments for People with Multiple Sclerosis Read more
Enesi Pharma and BARDA Drive Enter Public-Private Partnership to Develop ImplaVax Solid Dose Vaccine Delivery Technology Against Influenza Read more
Pulmatrix and Cipla enter into Definitive Agreement for the Development and Commercialization of Pulmazole Read more
Lynparza approved in EU for the treatment of germline BRCA-mutated HER2-negative advanced breast cancer Read more